library.onepin.app/vitamin-d3-plus-k2 Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider

OnePin Peptide Library · Metabolic

Metabolic Peptide Prescription drug

Vitamin D3 + K2

D3/K2 · Cholecalciferol + MK-7 · D3 K2

Vitamin D3 (cholecalciferol) is a fat-soluble secosteroid hormone precursor essential for calcium homeostasis, immune function, and hundreds of downstream gene-regulatory effects. Vitamin K2 (menaquinone, specifically MK-7 and MK-4 forms) is a fat-soluble cofactor essential for activating matrix Gla protein (MGP) and osteocalcin - proteins that direct calcium INTO bone and AWAY from arterial walls. The two vitamins are almost always co-supplemented because D3 increases calcium absorption and K2 determines where that calcium deposits.,Vitamin D deficiency is extraordinarily common - meta-analyses suggest 40-60% of adults in northern latitudes have serum 25(OH)D <30 ng/mL (deficient or insufficient). Modern indoor lifestyles, sunscreen use, obesity (vitamin D sequestration in adipose tissue), and darker skin pigmentation all contribute. Adequate vitamin D status is associated with better immune function, bone health, muscle strength, mood, and reduced all-cause mortality.,K2 supplementation without D3 is less commonly indicated (dietary K2 from natto, aged cheeses, egg yolks is usually adequate), but co-supplementation prevents the theoretical concern of D3-driven calcium causing vascular calcification in the absence of K2. The MK-7 form of K2 has a 72-hour half-life vs MK-4's 1-hour half-life, making MK-7 dramatically more efficient for daily or twice-weekly dosing.

Quick Start
Route
Oral
Start low
D3: 5,000 IU + K2 (MK-7) 100-200 mcg daily
Frequency
Once daily with fattiest meal of day
Timing
Anytime

Take with a fat-containing meal (fat-soluble vitamins require fat for absorption). Test 25(OH)D after 8-12 weeks to titrate dose. Typical target: 40-60 ng/mL.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Quick Start
Conservative start
D3: 5,000 IU + K2 (MK-7) 100-200 mcg daily · Oral · Once daily with fattiest meal of day
Lowest starting point. Hold about a week to assess tolerance before stepping up.
D3: 5,000 IU + K2 (MK-7) 100-200 mcg daily
Once daily with fattiest meal of day
Standard
Bone & Immune Baseline
5000 IU · Oral · Daily
human study · van Ballegooijen et al. 2017 (Int J Endocrinol)
5000 IU
Daily
01

How it works

Vitamin D3 is hydroxylated in the liver to 25-hydroxyvitamin D (calcidiol, the storage form measured in blood tests) and then in the kidneys and peripheral tissues to 1,25-dihydroxyvitamin D (calcitriol, the active hormone). Calcitriol binds the vitamin D receptor (VDR), a nuclear receptor expressed in virtually every tissue, and regulates transcription of >1,000 genes involved in calcium homeostasis, cell growth/differentiation, immune function, and antimicrobial peptide production (cathelicidin).,Vitamin K2 activates vitamin K-dependent proteins via gamma-carboxylation of glutamate residues. The key K2-dependent proteins are: (1) osteocalcin - binds calcium and incorporates it into bone hydroxyapatite, (2) matrix Gla protein (MGP) - prevents calcium deposition in arteries and soft tissues, (3) Gas6 - supports cell survival and phagocytosis. Without K2, these proteins circulate in inactive (uncarboxylated) form and calcium can deposit in inappropriate locations.,The D3+K2 synergy is mechanistic: D3 increases calcium absorption from the gut and mobilization from bone. K2 then directs that calcium into bone (via osteocalcin activation) and prevents arterial deposition (via MGP activation). The Rotterdam Study demonstrated this: high K2 intake was associated with 50% lower cardiovascular mortality and 57% lower arterial calcification.

Vitamin D3 is hydroxylated in the liver to 25-hydroxyvitamin D (calcidiol, the storage form measured in blood tests) and then in the kidneys and peripheral tissues to 1,25-dihydroxyvitamin D (calcitriol, the active hormone). Calcitriol binds the vitamin D receptor (VDR), a nuclear receptor expressed in virtually every tissue, and regulates transcription of >1,000 genes involved in calcium homeostasis, cell growth/differentiation, immune function, and antimicrobial peptide production (cathelicidin).,Vitamin K2 activates vitamin K-dependent proteins via gamma-carboxylation of glutamate residues. The key K2-dependent proteins are: (1) osteocalcin - binds calcium and incorporates it into bone hydroxyapatite, (2) matrix Gla protein (MGP) - prevents calcium deposition in arteries and soft tissues, (3) Gas6 - supports cell survival and phagocytosis. Without K2, these proteins circulate in inactive (uncarboxylated) form and calcium can deposit in inappropriate locations.,The D3+K2 synergy is mechanistic: D3 increases calcium absorption from the gut and mobilization from bone. K2 then directs that calcium into bone (via osteocalcin activation) and prevents arterial deposition (via MGP activation). The Rotterdam Study demonstrated this: high K2 intake was associated with 50% lower cardiovascular mortality and 57% lower arterial calcification.

02

What to expect

Early
Days 1–7

Weeks 1-4: Blood levels rising but subjective effects minimal. Test 25(OH)D after 8 weeks.

03

Evidence

HumanStrong
AnimalPresent
In-vitroPresent
2017Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data · Martineau AR, Jolliffe DA, Hooper RL, et al, BMJ ↗review
2015Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: a double-blind randomised clinical trial · Knapen MH, Braam LA, Drummen NE, et al, Thrombosis and Haemostasis ↗peer reviewed
2021The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial · Ronn SH, Harslof T, Pedersen SB, Langdahl BL, Osteoporosis International ↗peer reviewed
2013Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women · Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E, Osteoporosis International ↗peer reviewed
04

Interactions & stacking

What's safe to combine, and what belongs in a separate pin.

Safe & synergistic

StatinsSome statins (especially rosuvastatin) may modestly lower vitamin D levels - supplementation ensures adequate status.
Thyroid medicationsNo direct interaction but both rely on adequate cofactor status for optimal function.
MagnesiumMagnesium is required as a cofactor for every step of vitamin D metabolism (synthesis, transport, conversion to calcitriol, and VDR binding). Magnesium deficiency can cause functional vitamin D resistance even with adequate supplementation.
BoronBoron extends the half-life of active vitamin D and reduces its urinary excretion. Also supports K2 conversion from K1.

Keep separate

WarfarinVitamin K2 directly antagonizes warfarin's anticoagulant effect. Must NOT take K2 while on warfarin without close INR monitoring. DOACs (apixaban, rivaroxaban) are safe with K2 since they don't rely on vitamin K antagonism.
Thiazide diuretics (long-term high-dose)Thiazides reduce urinary calcium excretion; combined with high-dose D3 can theoretically cause hypercalcemia. Monitor serum calcium if both used chronically.
Orlistat and bile-acid sequestrantsReduce fat absorption and therefore fat-soluble vitamin absorption including D3/K2. Space dosing 4+ hours apart.
05

Pharmacokinetics

Illustrative plasma concentration · 24 h
Half-life
Vitamin D3: ~2-3 weeks (25(OH)D form). K2 MK-7: ~72 hours. K2 MK-4: ~1-2 hours.
Peak · Tmax
D3: ~7 days to peak serum 25(OH)D. K2 MK-7: ~4-6 hours. K2 MK-4: ~1-2 hours.
Elimination
D3: 8-12 weeks to steady state after dose change. K2 MK-7: stable steady state within 2-3 weeks.
Activity
D3 effects persist weeks after last dose due to long half-life and tissue storage. K2 MK-7 daily dosing maintains stable activated MGP/osteocalcin levels.

Storage. Store at room temperature (20-25C) in a cool, dry place. Protect from light. Capsules/softgels shelf-stable 2+ years. Liquid D3 drops stable when capped tightly. Both D3 and K2 are fat-soluble and stable in oil carriers.

06

Regulatory status

Classified as dietary supplements in the US - no prescription required for typical doses. Vitamin D is available as prescription at 50,000 IU (ergocalciferol D2 or cholecalciferol D3) for deficiency correction. K2 has no prescription equivalent.

Put it to work

Calculate, log & track

Open Vitamin D3 + K2 straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Vitamin D3 + K2 in the app →

Go deeper

The guide & community

The complete Vitamin D3 + K2 walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community